nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—UGT1A3—Cyproheptadine—allergic rhinitis	0.198	0.282	CbGbCtD
Irbesartan—PTGS1—Montelukast—allergic rhinitis	0.0477	0.0679	CbGbCtD
Irbesartan—PTGS1—Diphenhydramine—allergic rhinitis	0.0477	0.0679	CbGbCtD
Irbesartan—CYP1A2—Desloratadine—allergic rhinitis	0.0371	0.0528	CbGbCtD
Irbesartan—CYP2C9—Desloratadine—allergic rhinitis	0.0334	0.0476	CbGbCtD
Irbesartan—CYP2D6—Desloratadine—allergic rhinitis	0.0306	0.0435	CbGbCtD
Irbesartan—CYP2C8—Loratadine—allergic rhinitis	0.0275	0.0392	CbGbCtD
Irbesartan—CYP2C8—Montelukast—allergic rhinitis	0.0275	0.0392	CbGbCtD
Irbesartan—CYP1A2—Diphenhydramine—allergic rhinitis	0.0213	0.0303	CbGbCtD
Irbesartan—CYP3A4—Flunisolide—allergic rhinitis	0.0194	0.0277	CbGbCtD
Irbesartan—CYP2C9—Loratadine—allergic rhinitis	0.0192	0.0273	CbGbCtD
Irbesartan—CYP2C9—Montelukast—allergic rhinitis	0.0192	0.0273	CbGbCtD
Irbesartan—CYP2C9—Diphenhydramine—allergic rhinitis	0.0192	0.0273	CbGbCtD
Irbesartan—CYP3A4—Olopatadine—allergic rhinitis	0.0183	0.026	CbGbCtD
Irbesartan—CYP2D6—Loratadine—allergic rhinitis	0.0175	0.025	CbGbCtD
Irbesartan—CYP2D6—Diphenhydramine—allergic rhinitis	0.0175	0.025	CbGbCtD
Irbesartan—CYP2C8—Hydrocortisone—allergic rhinitis	0.0153	0.0218	CbGbCtD
Irbesartan—CYP3A4—Loratadine—allergic rhinitis	0.0112	0.0159	CbGbCtD
Irbesartan—CYP3A4—Montelukast—allergic rhinitis	0.0112	0.0159	CbGbCtD
Irbesartan—CYP3A4—Methylprednisolone—allergic rhinitis	0.0102	0.0145	CbGbCtD
Irbesartan—CYP2C8—Dexamethasone—allergic rhinitis	0.00952	0.0136	CbGbCtD
Irbesartan—CYP3A4—Triamcinolone—allergic rhinitis	0.00773	0.011	CbGbCtD
Irbesartan—CYP2C9—Dexamethasone—allergic rhinitis	0.00664	0.00945	CbGbCtD
Irbesartan—CYP3A4—Betamethasone—allergic rhinitis	0.00664	0.00945	CbGbCtD
Irbesartan—CYP3A4—Prednisolone—allergic rhinitis	0.00655	0.00932	CbGbCtD
Irbesartan—CYP3A4—Hydrocortisone—allergic rhinitis	0.00621	0.00884	CbGbCtD
Irbesartan—CYP2D6—Dexamethasone—allergic rhinitis	0.00607	0.00864	CbGbCtD
Irbesartan—CYP3A4—Dexamethasone—allergic rhinitis	0.00386	0.0055	CbGbCtD
Irbesartan—JUN—exocrine gland—allergic rhinitis	0.003	0.144	CbGeAlD
Irbesartan—JUN—respiratory system—allergic rhinitis	0.00156	0.0751	CbGeAlD
Irbesartan—EDNRA—Endothelins—CYSLTR1—allergic rhinitis	0.0015	0.0276	CbGpPWpGaD
Irbesartan—JUN—eye—allergic rhinitis	0.00143	0.0686	CbGeAlD
Irbesartan—EDNRA—bronchus—allergic rhinitis	0.00141	0.0678	CbGeAlD
Irbesartan—JUN—Fc-epsilon receptor I signaling in mast cells—MS4A2—allergic rhinitis	0.00135	0.0249	CbGpPWpGaD
Irbesartan—JUN—epithelium—allergic rhinitis	0.0013	0.0628	CbGeAlD
Irbesartan—JUN—bronchus—allergic rhinitis	0.00128	0.0618	CbGeAlD
Irbesartan—EDNRA—trachea—allergic rhinitis	0.00126	0.0608	CbGeAlD
Irbesartan—JUN—skin of body—allergic rhinitis	0.00124	0.0597	CbGeAlD
Irbesartan—JUN—IL12 signaling mediated by STAT4—IL13—allergic rhinitis	0.00121	0.0224	CbGpPWpGaD
Irbesartan—JUN—trachea—allergic rhinitis	0.00115	0.0555	CbGeAlD
Irbesartan—AGTR1—epithelium—allergic rhinitis	0.000982	0.0473	CbGeAlD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—allergic rhinitis	0.000941	0.0174	CbGpPWpGaD
Irbesartan—EDNRA—lung—allergic rhinitis	0.000908	0.0437	CbGeAlD
Irbesartan—JUN—Endothelins—CYSLTR1—allergic rhinitis	0.000878	0.0162	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—FOXP3—allergic rhinitis	0.000874	0.0161	CbGpPWpGaD
Irbesartan—AGTR1—trachea—allergic rhinitis	0.000869	0.0418	CbGeAlD
Irbesartan—JUN—lung—allergic rhinitis	0.000829	0.0399	CbGeAlD
Irbesartan—AGTR1—Allograft Rejection—HLA-G—allergic rhinitis	0.000794	0.0146	CbGpPWpGaD
Irbesartan—JUN—Calcium signaling in the CD4+ TCR pathway—IL4—allergic rhinitis	0.000758	0.014	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—IL13—allergic rhinitis	0.000748	0.0138	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—TLR1—allergic rhinitis	0.00073	0.0135	CbGpPWpGaD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—allergic rhinitis	0.000689	0.0127	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—IL17A—allergic rhinitis	0.000688	0.0127	CbGpPWpGaD
Irbesartan—AGTR1—ACE Inhibitor Pathway—TGFB1—allergic rhinitis	0.000652	0.012	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—IL5—allergic rhinitis	0.00064	0.0118	CbGpPWpGaD
Irbesartan—JUN—CD40/CD40L signaling—IL4—allergic rhinitis	0.000637	0.0118	CbGpPWpGaD
Irbesartan—JUN—Dexamethasone—Flunisolide—allergic rhinitis	0.000635	0.147	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Flunisolide—allergic rhinitis	0.000635	0.147	CbGdCrCtD
Irbesartan—EDNRA—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	0.000627	0.0116	CbGpPWpGaD
Irbesartan—AGTR1—lung—allergic rhinitis	0.000624	0.03	CbGeAlD
Irbesartan—EDNRA—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.000618	0.0114	CbGpPWpGaD
Irbesartan—JUN—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—allergic rhinitis	0.000613	0.0113	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.000598	0.011	CbGpPWpGaD
Irbesartan—CYP1A2—respiratory system—allergic rhinitis	0.000596	0.0287	CbGeAlD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.000576	0.0106	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—TLR1—allergic rhinitis	0.00057	0.0105	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.000561	0.0103	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—IL13—allergic rhinitis	0.000542	0.01	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.000529	0.00976	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—IL5—allergic rhinitis	0.000526	0.00971	CbGpPWpGaD
Irbesartan—PTGS1—respiratory system—allergic rhinitis	0.000517	0.0249	CbGeAlD
Irbesartan—AGTR1—Allograft Rejection—HLA-DQB1—allergic rhinitis	0.000495	0.00914	CbGpPWpGaD
Irbesartan—AGTR1—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	0.000492	0.00908	CbGpPWpGaD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—allergic rhinitis	0.00049	0.00904	CbGpPWpGaD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.000485	0.00894	CbGpPWpGaD
Irbesartan—EDNRA—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.000485	0.00894	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.000469	0.00866	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear SMAD2/3 signaling—IL5—allergic rhinitis	0.000468	0.00864	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—IL10—allergic rhinitis	0.000468	0.00863	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—IL5—allergic rhinitis	0.000464	0.00856	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—IL17A—allergic rhinitis	0.000463	0.00854	CbGpPWpGaD
Irbesartan—JUN—Estrogen signaling pathway—NFKB1—allergic rhinitis	0.000459	0.00846	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Receptor Signaling—SMAD3—allergic rhinitis	0.000456	0.00841	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—IL4—allergic rhinitis	0.000455	0.00839	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.00044	0.00812	CbGpPWpGaD
Irbesartan—EDNRA—G alpha (q) signalling events—TAC1—allergic rhinitis	0.00044	0.00812	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.000435	0.00802	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—FOXP3—allergic rhinitis	0.000433	0.00799	CbGpPWpGaD
Irbesartan—PTGS1—epithelium—allergic rhinitis	0.000432	0.0208	CbGeAlD
Irbesartan—JUN—IL12 signaling mediated by STAT4—CD4—allergic rhinitis	0.000431	0.00794	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000415	0.00766	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.000415	0.00766	CbGpPWpGaD
Irbesartan—PTGS1—skin of body—allergic rhinitis	0.000411	0.0198	CbGeAlD
Irbesartan—EDNRA—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000403	0.00744	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000401	0.0074	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.000394	0.00726	CbGpPWpGaD
Irbesartan—JUN—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	0.000388	0.00716	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—SMAD3—allergic rhinitis	0.000388	0.00716	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—IL10—allergic rhinitis	0.000385	0.0071	CbGpPWpGaD
Irbesartan—PTGS1—trachea—allergic rhinitis	0.000382	0.0184	CbGeAlD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.00038	0.00702	CbGpPWpGaD
Irbesartan—JUN—Regulation of Telomerase—SMAD3—allergic rhinitis	0.000379	0.007	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—IL4—allergic rhinitis	0.000374	0.00691	CbGpPWpGaD
Irbesartan—JUN—Osteopontin-mediated events—NFKB1—allergic rhinitis	0.000361	0.00667	CbGpPWpGaD
Irbesartan—JUN—RANKL/RANK Signaling Pathway—ICAM1—allergic rhinitis	0.000361	0.00666	CbGpPWpGaD
Irbesartan—AGTR1—G alpha (q) signalling events—TAC1—allergic rhinitis	0.000345	0.00637	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear SMAD2/3 signaling—IL10—allergic rhinitis	0.000343	0.00632	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.000341	0.00629	CbGpPWpGaD
Irbesartan—JUN—IL1-mediated signaling events—NFKB1—allergic rhinitis	0.000336	0.00619	CbGpPWpGaD
Irbesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—allergic rhinitis	0.00033	0.00609	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—IL4—allergic rhinitis	0.00033	0.00609	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear SMAD2/3 signaling—SMAD3—allergic rhinitis	0.00033	0.00608	CbGpPWpGaD
Irbesartan—JUN—Betamethasone—Hydrocortisone—allergic rhinitis	0.00033	0.0763	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Hydrocortisone—allergic rhinitis	0.00033	0.0763	CbGdCrCtD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000326	0.00601	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL13—allergic rhinitis	0.000324	0.00598	CbGpPWpGaD
Irbesartan—JUN—CD40/CD40L signaling—NFKB1—allergic rhinitis	0.000321	0.00591	CbGpPWpGaD
Irbesartan—CYP1A2—lung—allergic rhinitis	0.000317	0.0152	CbGeAlD
Irbesartan—EDNRA—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000316	0.00583	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000316	0.00583	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000315	0.00581	CbGpPWpGaD
Irbesartan—JUN—Betamethasone—Methylprednisolone—allergic rhinitis	0.000311	0.072	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Methylprednisolone—allergic rhinitis	0.000311	0.072	CbGdCrCtD
Irbesartan—JUN—IL12 signaling mediated by STAT4—TGFB1—allergic rhinitis	0.000309	0.0057	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.000309	0.0057	CbGpPWpGaD
Irbesartan—JUN—Betamethasone—Dexamethasone—allergic rhinitis	0.000306	0.0709	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Betamethasone—allergic rhinitis	0.000306	0.0709	CbGdCrCtD
Irbesartan—JUN—Androgen receptor signaling pathway—SMAD3—allergic rhinitis	0.000306	0.00564	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CCL11—allergic rhinitis	0.000305	0.00564	CbGpPWpGaD
Irbesartan—JUN—Betamethasone—Triamcinolone—allergic rhinitis	0.000299	0.0693	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Triamcinolone—allergic rhinitis	0.000299	0.0693	CbGdCrCtD
Irbesartan—JUN—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	0.000298	0.0055	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000291	0.00538	CbGpPWpGaD
Irbesartan—JUN—TWEAK Signaling Pathway—NFKB1—allergic rhinitis	0.000283	0.00523	CbGpPWpGaD
Irbesartan—JUN—Dexamethasone—Prednisolone—allergic rhinitis	0.000277	0.0642	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Prednisolone—allergic rhinitis	0.000277	0.0642	CbGdCrCtD
Irbesartan—PTGS1—lung—allergic rhinitis	0.000274	0.0132	CbGeAlD
Irbesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	0.000272	0.00502	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—SMAD3—allergic rhinitis	0.000268	0.00494	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—ICAM1—allergic rhinitis	0.000262	0.00484	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—SMAD3—allergic rhinitis	0.00026	0.0048	CbGpPWpGaD
Irbesartan—JUN—Selenium Metabolism and Selenoproteins—NFKB1—allergic rhinitis	0.000259	0.00478	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000248	0.00458	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CCL11—allergic rhinitis	0.00024	0.00442	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Receptor Signaling—NFKB1—allergic rhinitis	0.000232	0.00428	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000229	0.00422	CbGpPWpGaD
Irbesartan—JUN—RANKL/RANK Signaling Pathway—NFKB1—allergic rhinitis	0.000228	0.00421	CbGpPWpGaD
Irbesartan—JUN—IL-1 signaling pathway—NFKB1—allergic rhinitis	0.000228	0.00421	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000228	0.0042	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—MS4A2—allergic rhinitis	0.000224	0.00413	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—SMAD3—allergic rhinitis	0.000223	0.00412	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—TAC1—allergic rhinitis	0.000222	0.00409	CbGpPWpGaD
Irbesartan—JUN—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	0.00022	0.00405	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—ADIPOQ—allergic rhinitis	0.000219	0.00405	CbGpPWpGaD
Irbesartan—JUN—Fc-epsilon receptor I signaling in mast cells—NFKB1—allergic rhinitis	0.00021	0.00388	CbGpPWpGaD
Irbesartan—JUN—IL-3 Signaling Pathway—TGFB1—allergic rhinitis	0.000209	0.00385	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000207	0.00382	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL10—allergic rhinitis	0.000203	0.00374	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—NFKB1—allergic rhinitis	0.000202	0.00373	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—NFKB1—allergic rhinitis	0.000197	0.00364	CbGpPWpGaD
Irbesartan—JUN—BCR signaling pathway—NFKB1—allergic rhinitis	0.000195	0.0036	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Receptor Signaling—TGFB1—allergic rhinitis	0.000193	0.00356	CbGpPWpGaD
Irbesartan—JUN—Regulation of Telomerase—NFKB1—allergic rhinitis	0.000193	0.00356	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—TGFB1—allergic rhinitis	0.000191	0.00352	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—CD4—allergic rhinitis	0.000179	0.0033	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000179	0.0033	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000179	0.0033	CbGpPWpGaD
Irbesartan—JUN—TRAF6 Mediated Induction of proinflammatory cytokines—NFKB1—allergic rhinitis	0.000178	0.00329	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—TAC1—allergic rhinitis	0.000174	0.00321	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—ICAM1—allergic rhinitis	0.000173	0.00319	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—NFKB1—allergic rhinitis	0.000166	0.00306	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—NFKB1—allergic rhinitis	0.000163	0.003	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000162	0.00299	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000162	0.00299	CbGpPWpGaD
Irbesartan—JUN—MyD88 cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.000161	0.00297	CbGpPWpGaD
Irbesartan—JUN—Regulation of Telomerase—TGFB1—allergic rhinitis	0.000161	0.00296	CbGpPWpGaD
Irbesartan—JUN—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—allergic rhinitis	0.00016	0.00295	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—TGFB1—allergic rhinitis	0.000157	0.00289	CbGpPWpGaD
Irbesartan—JUN—MyD88 dependent cascade initiated on endosome—NFKB1—allergic rhinitis	0.000157	0.00289	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CCL11—allergic rhinitis	0.000157	0.00289	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—NFKB1—allergic rhinitis	0.000154	0.00284	CbGpPWpGaD
Irbesartan—JUN—Apoptosis Modulation and Signaling—NFKB1—allergic rhinitis	0.000153	0.00282	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—NFKB1—allergic rhinitis	0.000151	0.00279	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—allergic rhinitis	0.000151	0.00279	CbGpPWpGaD
Irbesartan—JUN—MyD88:Mal cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.000149	0.00274	CbGpPWpGaD
Irbesartan—JUN—B Cell Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.000145	0.00268	CbGpPWpGaD
Irbesartan—JUN—MyD88-independent cascade—NFKB1—allergic rhinitis	0.000143	0.00263	CbGpPWpGaD
Irbesartan—CYP2D6—Melatonin metabolism and effects—NFKB1—allergic rhinitis	0.000141	0.0026	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.00014	0.00259	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.000139	0.00257	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—NFKB1—allergic rhinitis	0.000136	0.00251	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—NFKB1—allergic rhinitis	0.000132	0.00244	CbGpPWpGaD
Irbesartan—JUN—Immune System—MS4A2—allergic rhinitis	0.00013	0.0024	CbGpPWpGaD
Irbesartan—JUN—Activated TLR4 signalling—NFKB1—allergic rhinitis	0.000128	0.00237	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—TGFB1—allergic rhinitis	0.000128	0.00237	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000127	0.00235	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—TAC1—allergic rhinitis	0.000125	0.00231	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CCL11—allergic rhinitis	0.000123	0.00227	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PTGDR2—allergic rhinitis	0.000122	0.00225	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—allergic rhinitis	0.000121	0.00223	CbGpPWpGaD
Irbesartan—CYP1A2—Melatonin metabolism and effects—NFKB1—allergic rhinitis	0.00012	0.00221	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—IL5—allergic rhinitis	0.000117	0.00215	CbGpPWpGaD
Irbesartan—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.000115	0.000526	CcSEcCtD
Irbesartan—Erythema—Hydrocortisone—allergic rhinitis	0.000115	0.000526	CcSEcCtD
Irbesartan—Malnutrition—Hydrocortisone—allergic rhinitis	0.000115	0.000526	CcSEcCtD
Irbesartan—Dizziness—Montelukast—allergic rhinitis	0.000115	0.000525	CcSEcCtD
Irbesartan—Bradycardia—Betamethasone—allergic rhinitis	0.000115	0.000525	CcSEcCtD
Irbesartan—Bradycardia—Dexamethasone—allergic rhinitis	0.000115	0.000525	CcSEcCtD
Irbesartan—EDNRA—Signaling by GPCR—TAC1—allergic rhinitis	0.000114	0.0021	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—TGFB1—allergic rhinitis	0.000113	0.00209	CbGpPWpGaD
Irbesartan—Angiopathy—Methylprednisolone—allergic rhinitis	0.000112	0.000515	CcSEcCtD
Irbesartan—Immune system disorder—Methylprednisolone—allergic rhinitis	0.000112	0.000512	CcSEcCtD
Irbesartan—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000112	0.000511	CcSEcCtD
Irbesartan—Arrhythmia—Triamcinolone—allergic rhinitis	0.000111	0.000508	CcSEcCtD
Irbesartan—Vision blurred—Prednisolone—allergic rhinitis	0.000111	0.000507	CcSEcCtD
Irbesartan—Arrhythmia—Methylprednisolone—allergic rhinitis	0.000111	0.000507	CcSEcCtD
Irbesartan—Vomiting—Montelukast—allergic rhinitis	0.00011	0.000505	CcSEcCtD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—TGFB1—allergic rhinitis	0.00011	0.00203	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—NFKB1—allergic rhinitis	0.000109	0.00202	CbGpPWpGaD
Irbesartan—Rash—Montelukast—allergic rhinitis	0.000109	0.000501	CcSEcCtD
Irbesartan—Dermatitis—Montelukast—allergic rhinitis	0.000109	0.0005	CcSEcCtD
Irbesartan—Ill-defined disorder—Prednisolone—allergic rhinitis	0.000109	0.000499	CcSEcCtD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—NFKB1—allergic rhinitis	0.000109	0.00201	CbGpPWpGaD
Irbesartan—Headache—Montelukast—allergic rhinitis	0.000109	0.000498	CcSEcCtD
Irbesartan—Visual impairment—Dexamethasone—allergic rhinitis	0.000109	0.000497	CcSEcCtD
Irbesartan—Visual impairment—Betamethasone—allergic rhinitis	0.000109	0.000497	CcSEcCtD
Irbesartan—Erythema—Triamcinolone—allergic rhinitis	0.000108	0.000495	CcSEcCtD
Irbesartan—UGT1A3—NRF2 pathway—TGFB1—allergic rhinitis	0.000108	0.00199	CbGpPWpGaD
Irbesartan—Malnutrition—Methylprednisolone—allergic rhinitis	0.000108	0.000494	CcSEcCtD
Irbesartan—Erythema—Methylprednisolone—allergic rhinitis	0.000108	0.000494	CcSEcCtD
Irbesartan—JUN—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	0.000108	0.00198	CbGpPWpGaD
Irbesartan—Angioedema—Prednisolone—allergic rhinitis	0.000107	0.000492	CcSEcCtD
Irbesartan—Ill-defined disorder—Hydrocortisone—allergic rhinitis	0.000106	0.000488	CcSEcCtD
Irbesartan—Malaise—Prednisolone—allergic rhinitis	0.000106	0.000485	CcSEcCtD
Irbesartan—EDNRA—Signaling by GPCR—IL5—allergic rhinitis	0.000106	0.00195	CbGpPWpGaD
Irbesartan—Dysgeusia—Triamcinolone—allergic rhinitis	0.000106	0.000485	CcSEcCtD
Irbesartan—JUN—BDNF signaling pathway—NFKB1—allergic rhinitis	0.000106	0.00195	CbGpPWpGaD
Irbesartan—Vertigo—Prednisolone—allergic rhinitis	0.000106	0.000483	CcSEcCtD
Irbesartan—Syncope—Prednisolone—allergic rhinitis	0.000105	0.000483	CcSEcCtD
Irbesartan—Angioedema—Hydrocortisone—allergic rhinitis	0.000105	0.00048	CcSEcCtD
Irbesartan—Malaise—Hydrocortisone—allergic rhinitis	0.000103	0.000474	CcSEcCtD
Irbesartan—Loss of consciousness—Prednisolone—allergic rhinitis	0.000103	0.000473	CcSEcCtD
Irbesartan—Vertigo—Hydrocortisone—allergic rhinitis	0.000103	0.000472	CcSEcCtD
Irbesartan—Nausea—Montelukast—allergic rhinitis	0.000103	0.000472	CcSEcCtD
Irbesartan—Syncope—Hydrocortisone—allergic rhinitis	0.000103	0.000471	CcSEcCtD
Irbesartan—Angiopathy—Dexamethasone—allergic rhinitis	0.000102	0.000468	CcSEcCtD
Irbesartan—Angiopathy—Betamethasone—allergic rhinitis	0.000102	0.000468	CcSEcCtD
Irbesartan—JUN—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	0.000102	0.00188	CbGpPWpGaD
Irbesartan—Hypertension—Prednisolone—allergic rhinitis	0.000101	0.000465	CcSEcCtD
Irbesartan—Loss of consciousness—Hydrocortisone—allergic rhinitis	0.000101	0.000462	CcSEcCtD
Irbesartan—Arrhythmia—Dexamethasone—allergic rhinitis	0.000101	0.000461	CcSEcCtD
Irbesartan—Arrhythmia—Betamethasone—allergic rhinitis	0.000101	0.000461	CcSEcCtD
Irbesartan—Ill-defined disorder—Triamcinolone—allergic rhinitis	0.0001	0.000459	CcSEcCtD
Irbesartan—Ill-defined disorder—Methylprednisolone—allergic rhinitis	0.0001	0.000458	CcSEcCtD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—NFKB1—allergic rhinitis	9.97e-05	0.00184	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	9.92e-05	0.00183	CbGpPWpGaD
Irbesartan—Hypertension—Hydrocortisone—allergic rhinitis	9.91e-05	0.000454	CcSEcCtD
Irbesartan—Discomfort—Prednisolone—allergic rhinitis	9.88e-05	0.000453	CcSEcCtD
Irbesartan—Angioedema—Triamcinolone—allergic rhinitis	9.87e-05	0.000452	CcSEcCtD
Irbesartan—Angioedema—Methylprednisolone—allergic rhinitis	9.85e-05	0.000451	CcSEcCtD
Irbesartan—AGTR1—GPCR downstream signaling—TAC1—allergic rhinitis	9.84e-05	0.00182	CbGpPWpGaD
Irbesartan—Erythema—Betamethasone—allergic rhinitis	9.8e-05	0.000449	CcSEcCtD
Irbesartan—Erythema—Dexamethasone—allergic rhinitis	9.8e-05	0.000449	CcSEcCtD
Irbesartan—Myalgia—Hydrocortisone—allergic rhinitis	9.77e-05	0.000447	CcSEcCtD
Irbesartan—Malaise—Triamcinolone—allergic rhinitis	9.74e-05	0.000446	CcSEcCtD
Irbesartan—Anxiety—Hydrocortisone—allergic rhinitis	9.73e-05	0.000446	CcSEcCtD
Irbesartan—Malaise—Methylprednisolone—allergic rhinitis	9.72e-05	0.000445	CcSEcCtD
Irbesartan—Vertigo—Triamcinolone—allergic rhinitis	9.71e-05	0.000445	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	9.7e-05	0.000444	CcSEcCtD
Irbesartan—Syncope—Triamcinolone—allergic rhinitis	9.69e-05	0.000444	CcSEcCtD
Irbesartan—Vertigo—Methylprednisolone—allergic rhinitis	9.69e-05	0.000444	CcSEcCtD
Irbesartan—Syncope—Methylprednisolone—allergic rhinitis	9.67e-05	0.000443	CcSEcCtD
Irbesartan—Discomfort—Hydrocortisone—allergic rhinitis	9.65e-05	0.000442	CcSEcCtD
Irbesartan—EDNRA—Signaling Pathways—CYSLTR1—allergic rhinitis	9.59e-05	0.00177	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PTGDR2—allergic rhinitis	9.59e-05	0.00177	CbGpPWpGaD
Irbesartan—Oedema—Prednisolone—allergic rhinitis	9.59e-05	0.000439	CcSEcCtD
Irbesartan—Anaphylactic shock—Prednisolone—allergic rhinitis	9.59e-05	0.000439	CcSEcCtD
Irbesartan—Loss of consciousness—Triamcinolone—allergic rhinitis	9.5e-05	0.000435	CcSEcCtD
Irbesartan—Loss of consciousness—Methylprednisolone—allergic rhinitis	9.47e-05	0.000434	CcSEcCtD
Irbesartan—JUN—TGF-beta Signaling Pathway—TGFB1—allergic rhinitis	9.45e-05	0.00174	CbGpPWpGaD
Irbesartan—Shock—Prednisolone—allergic rhinitis	9.43e-05	0.000432	CcSEcCtD
Irbesartan—Cough—Triamcinolone—allergic rhinitis	9.43e-05	0.000432	CcSEcCtD
Irbesartan—Anaphylactic shock—Hydrocortisone—allergic rhinitis	9.36e-05	0.000429	CcSEcCtD
Irbesartan—Oedema—Hydrocortisone—allergic rhinitis	9.36e-05	0.000429	CcSEcCtD
Irbesartan—Tachycardia—Prednisolone—allergic rhinitis	9.36e-05	0.000429	CcSEcCtD
Irbesartan—JUN—MAPK Signaling Pathway—NFKB1—allergic rhinitis	9.35e-05	0.00172	CbGpPWpGaD
Irbesartan—Hypertension—Triamcinolone—allergic rhinitis	9.33e-05	0.000427	CcSEcCtD
Irbesartan—Hypertension—Methylprednisolone—allergic rhinitis	9.31e-05	0.000426	CcSEcCtD
Irbesartan—Infection—Hydrocortisone—allergic rhinitis	9.3e-05	0.000426	CcSEcCtD
Irbesartan—Hyperhidrosis—Prednisolone—allergic rhinitis	9.27e-05	0.000425	CcSEcCtD
Irbesartan—EDNRA—Signaling Pathways—CCL11—allergic rhinitis	9.26e-05	0.00171	CbGpPWpGaD
Irbesartan—Shock—Hydrocortisone—allergic rhinitis	9.21e-05	0.000422	CcSEcCtD
Irbesartan—Myalgia—Triamcinolone—allergic rhinitis	9.2e-05	0.000421	CcSEcCtD
Irbesartan—Nervous system disorder—Hydrocortisone—allergic rhinitis	9.18e-05	0.000421	CcSEcCtD
Irbesartan—Arthralgia—Methylprednisolone—allergic rhinitis	9.18e-05	0.00042	CcSEcCtD
Irbesartan—Myalgia—Methylprednisolone—allergic rhinitis	9.18e-05	0.00042	CcSEcCtD
Irbesartan—AGTR1—GPCR downstream signaling—IL5—allergic rhinitis	9.15e-05	0.00169	CbGpPWpGaD
Irbesartan—Anxiety—Methylprednisolone—allergic rhinitis	9.15e-05	0.000419	CcSEcCtD
Irbesartan—Tachycardia—Hydrocortisone—allergic rhinitis	9.14e-05	0.000419	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	9.11e-05	0.000417	CcSEcCtD
Irbesartan—Skin disorder—Hydrocortisone—allergic rhinitis	9.1e-05	0.000417	CcSEcCtD
Irbesartan—Ill-defined disorder—Betamethasone—allergic rhinitis	9.1e-05	0.000417	CcSEcCtD
Irbesartan—Ill-defined disorder—Dexamethasone—allergic rhinitis	9.1e-05	0.000417	CcSEcCtD
Irbesartan—Discomfort—Triamcinolone—allergic rhinitis	9.09e-05	0.000416	CcSEcCtD
Irbesartan—Discomfort—Methylprednisolone—allergic rhinitis	9.07e-05	0.000415	CcSEcCtD
Irbesartan—Hyperhidrosis—Hydrocortisone—allergic rhinitis	9.05e-05	0.000415	CcSEcCtD
Irbesartan—Dry mouth—Triamcinolone—allergic rhinitis	9e-05	0.000412	CcSEcCtD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	8.97e-05	0.00165	CbGpPWpGaD
Irbesartan—Angioedema—Betamethasone—allergic rhinitis	8.96e-05	0.00041	CcSEcCtD
Irbesartan—Angioedema—Dexamethasone—allergic rhinitis	8.96e-05	0.00041	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—TAC1—allergic rhinitis	8.94e-05	0.00165	CbGpPWpGaD
Irbesartan—Anorexia—Hydrocortisone—allergic rhinitis	8.93e-05	0.000409	CcSEcCtD
Irbesartan—Malaise—Betamethasone—allergic rhinitis	8.84e-05	0.000405	CcSEcCtD
Irbesartan—Malaise—Dexamethasone—allergic rhinitis	8.84e-05	0.000405	CcSEcCtD
Irbesartan—Oedema—Triamcinolone—allergic rhinitis	8.82e-05	0.000404	CcSEcCtD
Irbesartan—Anaphylactic shock—Triamcinolone—allergic rhinitis	8.82e-05	0.000404	CcSEcCtD
Irbesartan—Vertigo—Betamethasone—allergic rhinitis	8.81e-05	0.000403	CcSEcCtD
Irbesartan—Vertigo—Dexamethasone—allergic rhinitis	8.81e-05	0.000403	CcSEcCtD
Irbesartan—Anaphylactic shock—Methylprednisolone—allergic rhinitis	8.8e-05	0.000403	CcSEcCtD
Irbesartan—Syncope—Dexamethasone—allergic rhinitis	8.79e-05	0.000403	CcSEcCtD
Irbesartan—Syncope—Betamethasone—allergic rhinitis	8.79e-05	0.000403	CcSEcCtD
Irbesartan—Infection—Triamcinolone—allergic rhinitis	8.76e-05	0.000401	CcSEcCtD
Irbesartan—Hypotension—Hydrocortisone—allergic rhinitis	8.75e-05	0.000401	CcSEcCtD
Irbesartan—Infection—Methylprednisolone—allergic rhinitis	8.74e-05	0.0004	CcSEcCtD
Irbesartan—Shock—Triamcinolone—allergic rhinitis	8.67e-05	0.000397	CcSEcCtD
Irbesartan—Shock—Methylprednisolone—allergic rhinitis	8.66e-05	0.000396	CcSEcCtD
Irbesartan—Nervous system disorder—Methylprednisolone—allergic rhinitis	8.63e-05	0.000395	CcSEcCtD
Irbesartan—JUN—Cellular Senescence—NFKB1—allergic rhinitis	8.62e-05	0.00159	CbGpPWpGaD
Irbesartan—Loss of consciousness—Dexamethasone—allergic rhinitis	8.62e-05	0.000395	CcSEcCtD
Irbesartan—Loss of consciousness—Betamethasone—allergic rhinitis	8.62e-05	0.000395	CcSEcCtD
Irbesartan—Paraesthesia—Prednisolone—allergic rhinitis	8.61e-05	0.000394	CcSEcCtD
Irbesartan—Tachycardia—Triamcinolone—allergic rhinitis	8.61e-05	0.000394	CcSEcCtD
Irbesartan—Tachycardia—Methylprednisolone—allergic rhinitis	8.59e-05	0.000393	CcSEcCtD
Irbesartan—Skin disorder—Methylprednisolone—allergic rhinitis	8.55e-05	0.000391	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	8.53e-05	0.000391	CcSEcCtD
Irbesartan—Hyperhidrosis—Triamcinolone—allergic rhinitis	8.52e-05	0.00039	CcSEcCtD
Irbesartan—Hyperhidrosis—Methylprednisolone—allergic rhinitis	8.51e-05	0.00039	CcSEcCtD
Irbesartan—Hypertension—Dexamethasone—allergic rhinitis	8.46e-05	0.000388	CcSEcCtD
Irbesartan—Hypertension—Betamethasone—allergic rhinitis	8.46e-05	0.000388	CcSEcCtD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	8.44e-05	0.00156	CbGpPWpGaD
Irbesartan—Paraesthesia—Hydrocortisone—allergic rhinitis	8.41e-05	0.000385	CcSEcCtD
Irbesartan—Myalgia—Betamethasone—allergic rhinitis	8.35e-05	0.000382	CcSEcCtD
Irbesartan—Myalgia—Dexamethasone—allergic rhinitis	8.35e-05	0.000382	CcSEcCtD
Irbesartan—Anxiety—Betamethasone—allergic rhinitis	8.32e-05	0.000381	CcSEcCtD
Irbesartan—Anxiety—Dexamethasone—allergic rhinitis	8.32e-05	0.000381	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—IL5—allergic rhinitis	8.31e-05	0.00153	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	8.26e-05	0.00152	CbGpPWpGaD
Irbesartan—Discomfort—Betamethasone—allergic rhinitis	8.25e-05	0.000378	CcSEcCtD
Irbesartan—Discomfort—Dexamethasone—allergic rhinitis	8.25e-05	0.000378	CcSEcCtD
Irbesartan—Dyspepsia—Hydrocortisone—allergic rhinitis	8.24e-05	0.000378	CcSEcCtD
Irbesartan—Hypotension—Methylprednisolone—allergic rhinitis	8.22e-05	0.000377	CcSEcCtD
Irbesartan—Pain—Prednisolone—allergic rhinitis	8.2e-05	0.000376	CcSEcCtD
Irbesartan—Decreased appetite—Hydrocortisone—allergic rhinitis	8.14e-05	0.000373	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	8.08e-05	0.00037	CcSEcCtD
Irbesartan—Fatigue—Hydrocortisone—allergic rhinitis	8.07e-05	0.00037	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	8.03e-05	0.000368	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	8.02e-05	0.000367	CcSEcCtD
Irbesartan—Pain—Hydrocortisone—allergic rhinitis	8.01e-05	0.000367	CcSEcCtD
Irbesartan—Oedema—Dexamethasone—allergic rhinitis	8e-05	0.000366	CcSEcCtD
Irbesartan—Anaphylactic shock—Betamethasone—allergic rhinitis	8e-05	0.000366	CcSEcCtD
Irbesartan—Anaphylactic shock—Dexamethasone—allergic rhinitis	8e-05	0.000366	CcSEcCtD
Irbesartan—Oedema—Betamethasone—allergic rhinitis	8e-05	0.000366	CcSEcCtD
Irbesartan—Infection—Betamethasone—allergic rhinitis	7.95e-05	0.000364	CcSEcCtD
Irbesartan—Infection—Dexamethasone—allergic rhinitis	7.95e-05	0.000364	CcSEcCtD
Irbesartan—Paraesthesia—Triamcinolone—allergic rhinitis	7.92e-05	0.000363	CcSEcCtD
Irbesartan—Feeling abnormal—Prednisolone—allergic rhinitis	7.9e-05	0.000362	CcSEcCtD
Irbesartan—Paraesthesia—Methylprednisolone—allergic rhinitis	7.9e-05	0.000362	CcSEcCtD
Irbesartan—Shock—Dexamethasone—allergic rhinitis	7.87e-05	0.000361	CcSEcCtD
Irbesartan—Shock—Betamethasone—allergic rhinitis	7.87e-05	0.000361	CcSEcCtD
Irbesartan—Dyspnoea—Triamcinolone—allergic rhinitis	7.86e-05	0.00036	CcSEcCtD
Irbesartan—Nervous system disorder—Betamethasone—allergic rhinitis	7.85e-05	0.000359	CcSEcCtD
Irbesartan—Nervous system disorder—Dexamethasone—allergic rhinitis	7.85e-05	0.000359	CcSEcCtD
Irbesartan—Thrombocytopenia—Dexamethasone—allergic rhinitis	7.83e-05	0.000359	CcSEcCtD
Irbesartan—Thrombocytopenia—Betamethasone—allergic rhinitis	7.83e-05	0.000359	CcSEcCtD
Irbesartan—Tachycardia—Betamethasone—allergic rhinitis	7.81e-05	0.000358	CcSEcCtD
Irbesartan—Tachycardia—Dexamethasone—allergic rhinitis	7.81e-05	0.000358	CcSEcCtD
Irbesartan—JUN—MAPK Signaling Pathway—TGFB1—allergic rhinitis	7.79e-05	0.00144	CbGpPWpGaD
Irbesartan—Dyspepsia—Triamcinolone—allergic rhinitis	7.76e-05	0.000355	CcSEcCtD
Irbesartan—Dyspepsia—Methylprednisolone—allergic rhinitis	7.74e-05	0.000355	CcSEcCtD
Irbesartan—Hyperhidrosis—Dexamethasone—allergic rhinitis	7.73e-05	0.000354	CcSEcCtD
Irbesartan—Hyperhidrosis—Betamethasone—allergic rhinitis	7.73e-05	0.000354	CcSEcCtD
Irbesartan—Feeling abnormal—Hydrocortisone—allergic rhinitis	7.72e-05	0.000353	CcSEcCtD
Irbesartan—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	7.66e-05	0.000351	CcSEcCtD
Irbesartan—Anorexia—Dexamethasone—allergic rhinitis	7.63e-05	0.000349	CcSEcCtD
Irbesartan—Anorexia—Betamethasone—allergic rhinitis	7.63e-05	0.000349	CcSEcCtD
Irbesartan—Urticaria—Prednisolone—allergic rhinitis	7.62e-05	0.000349	CcSEcCtD
Irbesartan—Fatigue—Triamcinolone—allergic rhinitis	7.6e-05	0.000348	CcSEcCtD
Irbesartan—Fatigue—Methylprednisolone—allergic rhinitis	7.59e-05	0.000347	CcSEcCtD
Irbesartan—Pain—Triamcinolone—allergic rhinitis	7.54e-05	0.000345	CcSEcCtD
Irbesartan—AGTR1—Signaling Pathways—CYSLTR1—allergic rhinitis	7.52e-05	0.00139	CbGpPWpGaD
Irbesartan—Hypotension—Betamethasone—allergic rhinitis	7.48e-05	0.000342	CcSEcCtD
Irbesartan—Hypotension—Dexamethasone—allergic rhinitis	7.48e-05	0.000342	CcSEcCtD
Irbesartan—Urticaria—Hydrocortisone—allergic rhinitis	7.44e-05	0.000341	CcSEcCtD
Irbesartan—Abdominal pain—Hydrocortisone—allergic rhinitis	7.4e-05	0.000339	CcSEcCtD
Irbesartan—Body temperature increased—Hydrocortisone—allergic rhinitis	7.4e-05	0.000339	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	7.29e-05	0.000334	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	7.29e-05	0.000334	CcSEcCtD
Irbesartan—AGTR1—Signaling Pathways—CCL11—allergic rhinitis	7.27e-05	0.00134	CbGpPWpGaD
Irbesartan—Feeling abnormal—Triamcinolone—allergic rhinitis	7.27e-05	0.000333	CcSEcCtD
Irbesartan—Feeling abnormal—Methylprednisolone—allergic rhinitis	7.25e-05	0.000332	CcSEcCtD
Irbesartan—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	7.19e-05	0.00033	CcSEcCtD
Irbesartan—Paraesthesia—Dexamethasone—allergic rhinitis	7.18e-05	0.000329	CcSEcCtD
Irbesartan—Paraesthesia—Betamethasone—allergic rhinitis	7.18e-05	0.000329	CcSEcCtD
Irbesartan—JUN—Signaling Pathways—PTGDR2—allergic rhinitis	7.16e-05	0.00132	CbGpPWpGaD
Irbesartan—Hypersensitivity—Prednisolone—allergic rhinitis	7.06e-05	0.000324	CcSEcCtD
Irbesartan—Dyspepsia—Dexamethasone—allergic rhinitis	7.04e-05	0.000323	CcSEcCtD
Irbesartan—Dyspepsia—Betamethasone—allergic rhinitis	7.04e-05	0.000323	CcSEcCtD
Irbesartan—JUN—Immune System—HLA-G—allergic rhinitis	7.04e-05	0.0013	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	7.03e-05	0.0013	CbGpPWpGaD
Irbesartan—Urticaria—Triamcinolone—allergic rhinitis	7e-05	0.000321	CcSEcCtD
Irbesartan—Urticaria—Methylprednisolone—allergic rhinitis	6.99e-05	0.00032	CcSEcCtD
Irbesartan—Body temperature increased—Triamcinolone—allergic rhinitis	6.97e-05	0.000319	CcSEcCtD
Irbesartan—Abdominal pain—Methylprednisolone—allergic rhinitis	6.95e-05	0.000319	CcSEcCtD
Irbesartan—Decreased appetite—Dexamethasone—allergic rhinitis	6.95e-05	0.000319	CcSEcCtD
Irbesartan—Decreased appetite—Betamethasone—allergic rhinitis	6.95e-05	0.000319	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	6.91e-05	0.000316	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Betamethasone—allergic rhinitis	6.91e-05	0.000316	CcSEcCtD
Irbesartan—Hypersensitivity—Hydrocortisone—allergic rhinitis	6.9e-05	0.000316	CcSEcCtD
Irbesartan—Fatigue—Betamethasone—allergic rhinitis	6.9e-05	0.000316	CcSEcCtD
Irbesartan—Fatigue—Dexamethasone—allergic rhinitis	6.9e-05	0.000316	CcSEcCtD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	6.88e-05	0.00127	CbGpPWpGaD
Irbesartan—Pain—Betamethasone—allergic rhinitis	6.84e-05	0.000313	CcSEcCtD
Irbesartan—Pain—Dexamethasone—allergic rhinitis	6.84e-05	0.000313	CcSEcCtD
Irbesartan—EDNRA—Signaling Pathways—TAC1—allergic rhinitis	6.73e-05	0.00124	CbGpPWpGaD
Irbesartan—Asthenia—Hydrocortisone—allergic rhinitis	6.72e-05	0.000308	CcSEcCtD
Irbesartan—Pruritus—Hydrocortisone—allergic rhinitis	6.63e-05	0.000303	CcSEcCtD
Irbesartan—Feeling abnormal—Dexamethasone—allergic rhinitis	6.59e-05	0.000302	CcSEcCtD
Irbesartan—Feeling abnormal—Betamethasone—allergic rhinitis	6.59e-05	0.000302	CcSEcCtD
Irbesartan—Gastrointestinal pain—Betamethasone—allergic rhinitis	6.54e-05	0.0003	CcSEcCtD
Irbesartan—Gastrointestinal pain—Dexamethasone—allergic rhinitis	6.54e-05	0.0003	CcSEcCtD
Irbesartan—JUN—Cellular responses to stress—NFKB1—allergic rhinitis	6.51e-05	0.0012	CbGpPWpGaD
Irbesartan—Hypersensitivity—Triamcinolone—allergic rhinitis	6.5e-05	0.000298	CcSEcCtD
Irbesartan—Hypersensitivity—Methylprednisolone—allergic rhinitis	6.48e-05	0.000297	CcSEcCtD
Irbesartan—Diarrhoea—Hydrocortisone—allergic rhinitis	6.41e-05	0.000293	CcSEcCtD
Irbesartan—Urticaria—Dexamethasone—allergic rhinitis	6.36e-05	0.000291	CcSEcCtD
Irbesartan—Urticaria—Betamethasone—allergic rhinitis	6.36e-05	0.000291	CcSEcCtD
Irbesartan—Dizziness—Prednisolone—allergic rhinitis	6.34e-05	0.00029	CcSEcCtD
Irbesartan—Asthenia—Triamcinolone—allergic rhinitis	6.33e-05	0.00029	CcSEcCtD
Irbesartan—Abdominal pain—Betamethasone—allergic rhinitis	6.32e-05	0.00029	CcSEcCtD
Irbesartan—Body temperature increased—Dexamethasone—allergic rhinitis	6.32e-05	0.00029	CcSEcCtD
Irbesartan—Abdominal pain—Dexamethasone—allergic rhinitis	6.32e-05	0.00029	CcSEcCtD
Irbesartan—Body temperature increased—Betamethasone—allergic rhinitis	6.32e-05	0.00029	CcSEcCtD
Irbesartan—Asthenia—Methylprednisolone—allergic rhinitis	6.31e-05	0.000289	CcSEcCtD
Irbesartan—EDNRA—Signaling Pathways—IL5—allergic rhinitis	6.26e-05	0.00115	CbGpPWpGaD
Irbesartan—Pruritus—Triamcinolone—allergic rhinitis	6.24e-05	0.000286	CcSEcCtD
Irbesartan—Pruritus—Methylprednisolone—allergic rhinitis	6.22e-05	0.000285	CcSEcCtD
Irbesartan—Dizziness—Hydrocortisone—allergic rhinitis	6.19e-05	0.000284	CcSEcCtD
Irbesartan—Rash—Prednisolone—allergic rhinitis	6.05e-05	0.000277	CcSEcCtD
Irbesartan—Dermatitis—Prednisolone—allergic rhinitis	6.04e-05	0.000277	CcSEcCtD
Irbesartan—Diarrhoea—Methylprednisolone—allergic rhinitis	6.02e-05	0.000276	CcSEcCtD
Irbesartan—Headache—Prednisolone—allergic rhinitis	6.01e-05	0.000275	CcSEcCtD
Irbesartan—Vomiting—Hydrocortisone—allergic rhinitis	5.95e-05	0.000273	CcSEcCtD
Irbesartan—Rash—Hydrocortisone—allergic rhinitis	5.9e-05	0.00027	CcSEcCtD
Irbesartan—Dermatitis—Hydrocortisone—allergic rhinitis	5.9e-05	0.00027	CcSEcCtD
Irbesartan—Headache—Hydrocortisone—allergic rhinitis	5.87e-05	0.000269	CcSEcCtD
Irbesartan—Dizziness—Triamcinolone—allergic rhinitis	5.83e-05	0.000267	CcSEcCtD
Irbesartan—Dizziness—Methylprednisolone—allergic rhinitis	5.82e-05	0.000266	CcSEcCtD
Irbesartan—Asthenia—Dexamethasone—allergic rhinitis	5.74e-05	0.000263	CcSEcCtD
Irbesartan—Asthenia—Betamethasone—allergic rhinitis	5.74e-05	0.000263	CcSEcCtD
Irbesartan—Nausea—Prednisolone—allergic rhinitis	5.7e-05	0.000261	CcSEcCtD
Irbesartan—JUN—Immune System—IL5—allergic rhinitis	5.67e-05	0.00105	CbGpPWpGaD
Irbesartan—Pruritus—Dexamethasone—allergic rhinitis	5.66e-05	0.000259	CcSEcCtD
Irbesartan—Pruritus—Betamethasone—allergic rhinitis	5.66e-05	0.000259	CcSEcCtD
Irbesartan—JUN—Signaling Pathways—CYSLTR1—allergic rhinitis	5.62e-05	0.00104	CbGpPWpGaD
Irbesartan—Vomiting—Triamcinolone—allergic rhinitis	5.61e-05	0.000257	CcSEcCtD
Irbesartan—Vomiting—Methylprednisolone—allergic rhinitis	5.59e-05	0.000256	CcSEcCtD
Irbesartan—Nausea—Hydrocortisone—allergic rhinitis	5.56e-05	0.000255	CcSEcCtD
Irbesartan—Rash—Triamcinolone—allergic rhinitis	5.56e-05	0.000255	CcSEcCtD
Irbesartan—Dermatitis—Triamcinolone—allergic rhinitis	5.55e-05	0.000254	CcSEcCtD
Irbesartan—Rash—Methylprednisolone—allergic rhinitis	5.55e-05	0.000254	CcSEcCtD
Irbesartan—Dermatitis—Methylprednisolone—allergic rhinitis	5.54e-05	0.000254	CcSEcCtD
Irbesartan—Headache—Triamcinolone—allergic rhinitis	5.52e-05	0.000253	CcSEcCtD
Irbesartan—Headache—Methylprednisolone—allergic rhinitis	5.51e-05	0.000252	CcSEcCtD
Irbesartan—Diarrhoea—Dexamethasone—allergic rhinitis	5.47e-05	0.000251	CcSEcCtD
Irbesartan—Diarrhoea—Betamethasone—allergic rhinitis	5.47e-05	0.000251	CcSEcCtD
Irbesartan—JUN—Signaling Pathways—CCL11—allergic rhinitis	5.43e-05	0.001	CbGpPWpGaD
Irbesartan—Dizziness—Betamethasone—allergic rhinitis	5.29e-05	0.000242	CcSEcCtD
Irbesartan—Dizziness—Dexamethasone—allergic rhinitis	5.29e-05	0.000242	CcSEcCtD
Irbesartan—AGTR1—Signaling Pathways—TAC1—allergic rhinitis	5.28e-05	0.000974	CbGpPWpGaD
Irbesartan—Nausea—Triamcinolone—allergic rhinitis	5.24e-05	0.00024	CcSEcCtD
Irbesartan—Nausea—Methylprednisolone—allergic rhinitis	5.23e-05	0.000239	CcSEcCtD
Irbesartan—Vomiting—Dexamethasone—allergic rhinitis	5.09e-05	0.000233	CcSEcCtD
Irbesartan—Vomiting—Betamethasone—allergic rhinitis	5.09e-05	0.000233	CcSEcCtD
Irbesartan—Rash—Betamethasone—allergic rhinitis	5.04e-05	0.000231	CcSEcCtD
Irbesartan—Rash—Dexamethasone—allergic rhinitis	5.04e-05	0.000231	CcSEcCtD
Irbesartan—Dermatitis—Betamethasone—allergic rhinitis	5.04e-05	0.000231	CcSEcCtD
Irbesartan—Dermatitis—Dexamethasone—allergic rhinitis	5.04e-05	0.000231	CcSEcCtD
Irbesartan—Headache—Dexamethasone—allergic rhinitis	5.01e-05	0.00023	CcSEcCtD
Irbesartan—Headache—Betamethasone—allergic rhinitis	5.01e-05	0.00023	CcSEcCtD
Irbesartan—AGTR1—Signaling Pathways—IL5—allergic rhinitis	4.91e-05	0.000906	CbGpPWpGaD
Irbesartan—Nausea—Betamethasone—allergic rhinitis	4.75e-05	0.000218	CcSEcCtD
Irbesartan—Nausea—Dexamethasone—allergic rhinitis	4.75e-05	0.000218	CcSEcCtD
Irbesartan—EDNRA—Signaling Pathways—SMAD3—allergic rhinitis	4.4e-05	0.000812	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DQB1—allergic rhinitis	4.39e-05	0.00081	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD4—allergic rhinitis	4.04e-05	0.000746	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TAC1—allergic rhinitis	3.94e-05	0.000728	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL5—allergic rhinitis	3.67e-05	0.000677	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—NFKB1—allergic rhinitis	3.48e-05	0.000643	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SMAD3—allergic rhinitis	3.45e-05	0.000637	CbGpPWpGaD
Irbesartan—JUN—Immune System—ICAM1—allergic rhinitis	3.21e-05	0.000591	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SMAD3—allergic rhinitis	2.58e-05	0.000476	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD4—allergic rhinitis	2.36e-05	0.000435	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NFKB1—allergic rhinitis	2.24e-05	0.000413	CbGpPWpGaD
Irbesartan—JUN—Immune System—NFKB1—allergic rhinitis	2.03e-05	0.000374	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TGFB1—allergic rhinitis	1.86e-05	0.000344	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NFKB1—allergic rhinitis	1.76e-05	0.000324	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TGFB1—allergic rhinitis	1.46e-05	0.00027	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NFKB1—allergic rhinitis	1.31e-05	0.000242	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TGFB1—allergic rhinitis	1.09e-05	0.000202	CbGpPWpGaD
